TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Cancer Policy: Reports Lists 10 Recommendations TO Improve Quality of Care, Measurement April 9, 1999